New insights into the metal-induced oxidative degradation pathways of transthyretin
- PMID: 30887985
- PMCID: PMC6452628
- DOI: 10.1039/c9cc00682f
New insights into the metal-induced oxidative degradation pathways of transthyretin
Abstract
The amyloidogenic mechanism of transthyretin is still debated but understanding it fully could lend insight into disease progression and potential therapeutics. Transthyretin was investigated revealing a metal-induced (Cr/Cu) oxidation pathway leading to N-terminal backbone fragmentation and oligomer formation; previously hidden details were revealed only by FT-IM-Orbitrap MS and surface-induced dissociation.
Conflict of interest statement
Conflicts of interest
There are no conflicts to declare.
Figures
References
-
- Palha Joana A., Clinical Chemistry and Laboratory Medicine, 2002, 40, 1292. - PubMed
-
- Monaco HL, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000, 1482, 65–72. - PubMed
-
- Lai Z, Colón W and Kelly JW, Biochemistry, 1996, 35, 6470–6482. - PubMed
-
- Yoshiki S, Jeffery WK and Shu-ichi I, Current Pharmaceutical Design, 2008, 14, 3219–3230. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
